Aclaris Therapeutics (ACRS) Tops Q2 EPS by 3c, misses on revenue

Go back to Aclaris Therapeutics (ACRS) Tops Q2 EPS by 3c, misses on revenue
(NASDAQ: ACRS) Delayed: 5.72 +0.15 (2.69%)
Previous Close $5.57    52 Week High $33.88 
Open $5.63    52 Week Low $14.12 
Day High $5.77    P/E N/A 
Day Low $5.50    EPS $0.00 
Volume 2,879,401